Browsing Tag
National Institutes of Health
11 posts
Children’s Hospital of Philadelphia study uncovers missing RNA fragments as potential key to targeted immunotherapy for pediatric brain tumors
CHOP researchers discover that missing RNA microexons in pediatric brain tumors create a targetable NRCAM variant, opening new paths for safer immunotherapy.
Virpax Pharmaceuticals extends collaboration with NIH for pain management drug development
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a company focused on innovative pharmaceutical solutions for pain management, announced the extension…
Thermo Fisher Scientific and NCI launch myeloMATCH trial to advance AML and MDS treatment
In a significant advancement in cancer treatment, Thermo Fisher Scientific Inc. (NYSE: TMO) has partnered with the National…
RevBio secures NIH grant for game-changing TETRANITE Technology
RevBio, Inc., revealed that it has secured a substantial grant of up to $3.4 million, to be disbursed…
BITT secures NIH funding for pioneering Sjögren’s syndrome treatment
Boston Immune Technologies and Therapeutics, Inc. (BITT), a leading clinical-stage biotechnology firm specializing in tumor necrosis factor superfamily…
US NIH stops ACTIV-2 phase 3 trial of Covid-19 drug candidate SAB-185
SAB Biotherapeutics said that the US National Institutes of Health (NIH) is discontinuing the phase 3 ACTIV-2 trial…
Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy
Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated…
Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005
Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate…
Cancer Targeted Technology gets NIH grant to support CTT1403 trial
Cancer Targeted Technology (CTT), a Seattle-based biotech company, has secured a grant of $1.44 million from the US…
Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise
Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1…